↓ Skip to main content

Cochrane Database of Systematic Reviews

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

Overview of attention for article published in Cochrane database of systematic reviews, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
194 Mendeley
Title
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
Published in
Cochrane database of systematic reviews, May 2019
DOI 10.1002/14651858.cd010455.pub3
Pubmed ID
Authors

Lise M Verhoef, Bart JF van den Bemt, Aatke van der Maas, Johanna E Vriezekolk, Marlies E Hulscher, Frank HJ van den Hoogen, Wilco CH Jacobs, Noortje van Herwaarden, Alfons A den Broeder

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Unknown 193 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 14%
Student > Ph. D. Student 18 9%
Other 16 8%
Researcher 16 8%
Student > Bachelor 14 7%
Other 31 16%
Unknown 72 37%
Readers by discipline Count As %
Medicine and Dentistry 66 34%
Nursing and Health Professions 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Psychology 6 3%
Biochemistry, Genetics and Molecular Biology 5 3%
Other 15 8%
Unknown 82 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2023.
All research outputs
#1,327,674
of 25,462,162 outputs
Outputs from Cochrane database of systematic reviews
#2,836
of 12,090 outputs
Outputs of similar age
#29,088
of 364,266 outputs
Outputs of similar age from Cochrane database of systematic reviews
#51
of 143 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,266 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 143 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.